X0306 4 2014-07-15 0 0001488613 Foundation Medicine, Inc. FMI 0001585017 Ryan Jason 150 SECOND STREET C/O FOUNDATION MEDICINE, INC. CAMBRIDGE MA 02141 0 1 0 0 Senior Vice President, Finance Common Stock 2014-07-15 4 M 0 3541 0.08 A 3541 D Common Stock 2014-07-15 4 S 0 3541 27.2203 D 0 D Stock Option (right to buy) 0.08 2014-07-15 4 M 0 3541 0.00 D 2021-06-15 Common Stock 3541 22086 D The exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2013. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2013. The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.79 to $27.70, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. This option was granted on June 15, 2011. Twenty-five percent vested on May 16, 2012 and an additional 6.25% vests each successive quarter thereafter until fully vested on May 16, 2015. Robert W. Hesslein, as Attorney-in-Fact for Jason Ryan 2014-07-17